MarketLens
Sign Up

What's Behind Bausch + Lomb's Bold AI Mandate

8 months ago
SHARE THIS ON:

What's Behind Bausch + Lomb's Bold AI Mandate

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•4 days ago

K2 Vision Has Been Recognized as the Highest-Volume Light Adjustable Lens practice in the world

K2 Vision performed 5,000+ Light Adjustable Lens procedures and was recognized by RxSight as the highest-volume LAL practice globally, reflecting strong adoption of the premium intraocular lens.
Stock News•1 months ago

Bausch + Lomb Advances Dry Eye Drug to Phase III as Pain Candidate Hits Phase Ib Goal

Bausch + Lomb will advance its dual-action dry eye treatment to Phase III after a Phase II study showed significant corneal staining improvement at day 15, despite missing the primary endpoint at day ...
Stock News•3 months ago

Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care

Bausch + Lomb launched Orphia, an AI-powered digital health platform for eye care providers. The brand-agnostic platform aims to reduce time spent on disconnected tools.

Breaking News

View All →

Top Headlines

View More →
Stock News•1 hour ago

OpenAI Is Reportedly Raising $30 Billion. Which Chip Stock Gains the Most?

Stock News•1 hour ago

Apple (AAPL) Stock Sinks As Market Gains: What You Should Know

Stock News•1 hour ago

Annaly Capital Management (NLY) Surpasses Q3 Earnings Estimates

Stock News•1 hour ago

Alphabet (GOOGL) Stock Declines While Market Improves: Some Information for Investors

Stock News•1 hour ago

Alphabet Inc. (GOOG) Stock Drops Despite Market Gains: Important Facts to Note